A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Endocarditis is an inflammation of the endocardium, the inner lining of the heart and heart valves. Most cases are caused by a bacterial infection. Endocarditis is a serious ailment that can lead to severe medical complications, and can even be fatal if not treated.
The most common symptom of endocarditis is fever. The fever may be high or low, and it may seem to come and go. Other common symptoms include the following:
Most causes of endocarditis are related to a bacterial infection. Usually your body fights off an infection, even if bacteria reach your heart. But when heart valves or tissue are damaged, they provide a good place for bacteria to lodge and multiply. Your risk of endocarditis increases if you have heart disease or mechanical heart valves. Procedures that increase your risk of endocarditis include dental procedures that irritate the gums, tonsillectomy, adenoidectomy, intestinal and respiratory surgery, gallbladder surgery, cystoscopy, bronchoscopy, and vaginal delivery with an infection present.
Your health care provider will listen to your heart and lungs, take your pulse, and check your eyes and skin. They likely will order several tests, which could include blood tests, urine analysis, an echocardiogram, a computed tomography (CT) scan, a Magnetic Resonance Imaging (MRI) and a cinefluoroscopy (a motion-picture type heart scan). Usually, your provider will admit you to the hospital, possibly in intensive care, until your symptoms are under control.
Your health care provider will treat endocarditis with high doses of antibiotics, almost always intravenously. Sometimes, surgery is also required.
Endocarditis is usually treated with a combination of two or three antibiotics such as penicillin, gentamicin, vancomycin, cefazolin, ceftriaxone, nafcillin, oxacillin, rifampin, and ampicillin. Treatment is determined by what type of bacteria is infecting your heart and generally takes 2 - 6 weeks. In patients with endocarditis, long term daily use of aspirin does not reduce the risk of embolic events, but may be associated with a higher level of bleeding.
Endocarditis has serious ramifications and requires aggressive medical treatment. Alternative therapies may be used concurrently to help reduce severity, duration, and progression of disease, but endocarditis should never be treated with alternative therapies alone. Inform all of your health care providers of any alternative medicine therapies or supplements you are using.
Following these nutritional tips may help reduce symptoms:
You may address nutritional deficiencies with the following supplements:
Herbs are generally a safe way to strengthen and tone the body's systems. As with any therapy, you should work with your health care provider to determine the safest and most effective botanical therapies before starting any treatment. You may use herbs as dried extracts (capsules, powders, teas), glycerites (glycerine extracts), or tinctures (alcohol extracts). Unless otherwise indicated, make teas with 1 tsp. herb per cup of hot water. Steep covered 5 - 10 minutes for leaf or flowers, and 10 - 20 minutes for roots. Drink 2 - 4 cups per day. You may use tinctures alone or in combination as noted.
Although very few studies have examined the effectiveness of specific homeopathic therapies, professional homeopaths may consider the following remedies as a supplemental treatment for the symptoms of endocarditis, as long as the underlying infection has been appropriately treated. Before prescribing a remedy, homeopaths take into account a person's constitutional type -- your physical, emotional, and psychological makeup. An experienced homeopath assesses all of these factors when determining the most appropriate treatment for each individual.
Acupuncture may help improve immunity and strengthen heart function.
In addition to monitoring your condition while you are in the hospital, your health care provider will order follow up procedures, such as blood tests, to determine how well the prescribed treatment is working.
Heart infection - endocarditis
Bope. Conn's Current Therapy 2010, 1st ed. Philadelphia, PA: Saunders, An Imprint of Elsevier; 2009.
Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea -- a review. J Am Coll Nutr. 2006;25(2):79-99.
Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999;69(6):1086-1107.
Chan KL, Tam J, Dumesnil JG, et al. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis. 2008; 46(1):37-41.
Conn. Conn's Current Therapy, 2010, 1st ed. Philadelphia, PA: Saunders, An Imprint of Elsevier; 2009.
Fernandez Guerrero ML, Gonzalez Lopez JJ, Goyenechea A, Fraile J, de Gorgolas M. Endocarditis caused by Stphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. Medicine (Baltimore). 2009; 88(1):1-22.
Hayes DD. New guidelines for preventing infective endocarditis. Nursing. 2007;37(8):22-3.
Mandell. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed. Philadelphia, PA: Churchill Livingstone, An Imprint of Elsevier; 2009.
Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009; 169(5):463-73.
Pallasch TJ. Perspectives on the 2007 AHA Endocarditis Prevention Guidelines. J Calif Dent Assoc. 2007;35(7):507-13.
Shimokoawa T, Kasegawa H, Matsuyama S, et al. Long-term outcome of mitral valve repair for infective endocarditis. Ann Thorac Surg. 2009; 88(3):733-9; discussion 739.
Syed FF, Millar BC, Prendergast BD. Molecular technology in context: a current review of diagnosis and management of infective endocarditis. Prog Cardiovasc Dis. 2007;50(3):181-97.
Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory properties.Yonsei Med J. 2005;46(5):585-96.
Zapfe jun G. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II. Phytomedicine. 2001;8:262-6.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885